Octagon Capital Advisors LP TRVI Holdings History
Octagon Capital Advisors LP's Trevi Therapeutics Inc Holding Summary
As of 2025-03-31, Octagon Capital Advisors LP held 3.32 Mil shares of Trevi Therapeutics Inc(TRVI), totaling $20.90 Mil. This investment constitutes 4.04% of their stock portfolio, and Octagon Capital Advisors LP now holds 3.27% of the outstanding Trevi Therapeutics Inc(TRVI) stock.
The initial trade took place in 2025Q1. And since then Octagon Capital Advisors LP has made 1 purchases of TRVI, at an average price of $4.77, for a total of 3.32 Mil shares. Based on historical transaction data and TRVI's current price of $5.61, Octagon Capital Advisors LP's estimated gain on his TRVI holdings is $2.79 Mil, reflecting a 17.61% gain to date.
Octagon Capital Advisors LP TRVI ($5.61) Holding Chart
Octagon Capital Advisors LP TRVI ($5.61) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
